Status:
COMPLETED
Adjuvant Chemotherapy Trial of TS-1 for Gastric Cancer (ACTS-GC)
Lead Sponsor:
Taiho Pharmaceutical Co., Ltd.
Conditions:
Gastric Cancer
Eligibility:
All Genders
20-80 years
Phase:
PHASE3
Brief Summary
This controlled study is designed to evaluate the efficacy of TS-1 on survival compared with surgery alone. Patients will be randomly assigned to receive either surgery alone or surgery followed by tr...
Eligibility Criteria
Inclusion
- Age 20 to 80
- Hematopoietic WBC ≥ 4,000/mm\^3 Platelet ≥ 100,000/mm\^3
- Hepatic AST and ALT ≤ 2.5 times upper limit of normal(ULN) Total bilirubin ≤ 1.5 mg/dL
- Renal Creatinine ≤ULN
Exclusion
- Prior anticancer treatment
Key Trial Info
Start Date :
September 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00152217
Start Date
September 1 2001
End Date
December 1 2010
Last Update
July 7 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Center Hospital
5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan